GlassScriptPhysician profile
Michael M Binner
NPI 1699270694
$10,220.51
in general payments reported to CMS, 2019-2025
39 companies · $2,228 in 2025
The $2,228 reported for 2025 was more than what 82% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $2,038 · 2024: $5,954 · 2025: $2,228.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,121 · Travel and Lodging: $3,001 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,120.91 |
| Travel and Lodging | $3,000.60 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $1,715.31 | 2023-2025 | Urolift, Barrigel |
| Profound Medical Corp. | $1,345.30 | 2024-2025 | Tulsa-Pro |
| Procept Biorobotics Corporation | $967.52 | 2023-2025 | Aquabeam System, Aquabeam Robotic System |
| Angiodynamics, INC. | $878.04 | 2024 | Nanoknife |
| Axonics, INC. | $813.18 | 2023-2024 | Axonics |
| Boston Scientific Corporation | $577.47 | 2023-2025 | Axonics, Spaceoar Vue System - 10ml, Ams 800 Artificial Urinary Sphincter |
| Edap Technomed INC | $534.07 | 2023-2024 | |
| Sumitomo Pharma America, INC. | $344.18 | 2023-2025 | Gemtesa, Orgovyx |
| Janssen Biotech, INC. | $339.42 | 2024-2025 | Erleada, Akeega |
| Urogen Pharma, INC. | $236.88 | 2023-2025 | Jelmyto |
| Olympus America INC. | $236.83 | 2023-2025 | Itind System |
| Myriad Genetic Laboratories, INC. | $225.45 | 2023-2024 | Prolaris, Myrisk |
| Endo USA, INC. | $185.54 | 2024-2025 | Xiaflex, Aveed, Edex |
| Ferring Pharmaceuticals INC. | $164.62 | 2025 | Adstiladrin |
| Intuitive Surgical, INC. | $151.69 | 2024 |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Agiliti Surgical, INC. | $151.61 | 2023 | Sonablate |
| Pfizer INC. | $149.50 | 2023-2024 | |
| Progenics Pharmaceuticals, INC. | $125.00 | 2023 | Pylarify |
| Astellas Pharma US INC | $122.89 | 2023-2025 | Xtandi, Myrbetriq |
| Janssen Scientific Affairs, LLC | $93.95 | 2025 | Balversa, Akeega, Erleada |
| Blue Earth Diagnostics | $93.42 | 2024-2025 | Posluma |
| Valencia Technologies Corporation | $88.67 | 2025 | Ecoin Device Kit |
| Verity Pharmaceuticals INC. | $77.77 | 2023-2024 | Trelstar, Tlando |
| Dendreon Pharmaceuticals LLC | $72.47 | 2023-2025 | Provenge |
| Tolmar, INC. | $67.41 | 2024-2025 | Eligard |
| Sun Pharmaceutical Industries INC. | $64.37 | 2024 | |
| Calyxo, INC. | $64.17 | 2025 | Cvac Aspiration System |
| Civco Medical Instruments | $41.68 | 2025 | |
| Laborie Medical Technologies Corp. | $40.77 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| Novartis Pharmaceuticals Corporation | $30.76 | 2024 | |
| Telix Pharmaceuticals | $28.17 | 2025 | Illuccix |
| Abbvie INC. | $27.41 | 2024 | |
| Bioprotect Medical, INC. | $26.19 | 2025 | Bioprotect Balloon Implant System |
| Coloplast Corp | $25.26 | 2023 | Speedicath |
| Vertex Pharmaceuticals Incorporated | $24.85 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $24.12 | 2024 | |
| Karl Storz Endoscopy-America | $23.09 | 2025 | |
| Kerecis Limited | $21.66 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Antares Pharma, INC. | $19.82 | 2025 | Xyosted |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Binner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.